CRMD
CorMedix Inc. · Healthcare
Insiders bought $276K of CorMedix Inc. in the last 12 months
1 insider bought on 1 day.
CRMD over the last year
Largest buyers, last 12 months
CRMD after insider buys
3 months after each buy, from the first price a copier could get.
5 buys since 2017 with 3 months of prices.
Every filing
52 insider filings since 2016, newest first
About CorMedix Inc.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.